las41004
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01360944)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- las41004
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02180464 | Phase 2 | Jun 1, 2014 | Almirall, Bioskin GmbH |
| NCT02111499 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2014 | Almirall, proDERM GmbH |
| NCT01462643 | Phase 2 | Aug 1, 2011 | Almirall, proDERM GmbH |
| NCT01360944 | Phase 2 | May 1, 2011 | Almirall, Sciderm GmbH |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Almirall | For profit | 4 | 4 | 1 | 2011 |
| proDERM GmbH | For profit | 2 | 0 | 1 | 2011 |
| Bioskin GmbH | For profit | 1 | 0 | 1 | 2014 |
| Sciderm GmbH | For profit | 1 | 0 | 1 | 2011 |
4 organizations
Page 1 / 1